For example, we replicated the association of CDCP1 with lung cancer risk reported within the EPIC cohort and also found concordant evidence for risk proteins, such as CEACAM5, identified within up to three years before diagnosis in the INTEGRAL project21,22,27. Here, CEACAM5 is linked to lung carcinoma.